You are here: Industry Insights > PharmaJet

News List

Immunomic partners EpiVax and PharmaJet on Covid-19 vaccine pharmaceutical-technology
April 14, 2020
Biotechnology firm Immunomic Therapeutics has partnered with EpiVax and PharmaJet to develop a vaccine candidate against Covid-19 infection.
PharmaJet, Mundipharma unite to expand needle-free technology worldwide biospectrumasia
July 26, 2018
An exclusive partnership for the multinational healthcare organization to market and distribute PharmaJet's Tropis® and Stratis® needle-free devices across more than 120 markets worldwide
PharmaJet Releases Positive Phase I Results for Hantavirus Vaccines biospace
March 15, 2018
PharmaJet, headquartered in Golden, Colorado, released positive interim results from the U.S. Army’s Phase I clinical trial of two hantavirus vaccines to prevent hemorrhagic fever with renal syndrome (HFRS).
PharmaJet unites with Genexine to develop DNA vaccine biospectrumasia
February 26, 2018
DNA vaccines can be used as targeted therapeutic vaccines to induce an immune response which can detect and destroy infectious diseases and potentially cancer
Study Shows Superiority of PharmaJet Needle-Free Injector for Poliovirus Vaccine Administration biospace
January 24, 2018
PharmaJet, the maker of innovative, needle-free injection technology, announced that a study was published in Heliyon Journal showing PharmaJet needle-free injection is superior to needle and syringe for fractional dose poliovirus vaccine campaigns.(1)